ZA9010067B - Novel 2-substituted 4-(3-alkyl-5-tert-butyl-4-hydroxyphenyl)thiazoles,processes for their preparation,pharmaceuticals containing them and their use - Google Patents

Novel 2-substituted 4-(3-alkyl-5-tert-butyl-4-hydroxyphenyl)thiazoles,processes for their preparation,pharmaceuticals containing them and their use

Info

Publication number
ZA9010067B
ZA9010067B ZA9010067A ZA9010067A ZA9010067B ZA 9010067 B ZA9010067 B ZA 9010067B ZA 9010067 A ZA9010067 A ZA 9010067A ZA 9010067 A ZA9010067 A ZA 9010067A ZA 9010067 B ZA9010067 B ZA 9010067B
Authority
ZA
South Africa
Prior art keywords
formula
radical
alkyl
group
hydrogen atom
Prior art date
Application number
ZA9010067A
Other languages
English (en)
Inventor
Werner Thorwart
Thorwart Werner
Rudolf Schleyerbach
Schleyerbach Rudolf
Robert Bartlett
Bartlett Robert
Klaus Ulrich Weithmann
Ulrich Weithmann Klaus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA9010067B publication Critical patent/ZA9010067B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Lubricants (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA9010067A 1989-12-15 1990-12-14 Novel 2-substituted 4-(3-alkyl-5-tert-butyl-4-hydroxyphenyl)thiazoles,processes for their preparation,pharmaceuticals containing them and their use ZA9010067B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3941438A DE3941438A1 (de) 1989-12-15 1989-12-15 Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung

Publications (1)

Publication Number Publication Date
ZA9010067B true ZA9010067B (en) 1991-09-25

Family

ID=6395527

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9010067A ZA9010067B (en) 1989-12-15 1990-12-14 Novel 2-substituted 4-(3-alkyl-5-tert-butyl-4-hydroxyphenyl)thiazoles,processes for their preparation,pharmaceuticals containing them and their use

Country Status (17)

Country Link
US (1) US5137897A (fi)
EP (1) EP0432740B1 (fi)
JP (1) JPH0517459A (fi)
KR (1) KR910011813A (fi)
AT (1) ATE119527T1 (fi)
AU (1) AU630261B2 (fi)
CA (1) CA2032282A1 (fi)
DE (1) DE3941438A1 (fi)
FI (1) FI906141A (fi)
HU (1) HU209584B (fi)
IE (1) IE904515A1 (fi)
IL (1) IL96659A0 (fi)
NO (1) NO905411L (fi)
NZ (1) NZ236453A (fi)
PT (1) PT96181A (fi)
RU (2) RU2021264C1 (fi)
ZA (1) ZA9010067B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
EP0548017A1 (de) * 1991-12-18 1993-06-23 Ciba-Geigy Ag Neue Thiazole
TW211005B (fi) * 1991-12-18 1993-08-11 Ciba Geigy Ag
DE19502209A1 (de) 1995-01-25 1996-08-01 Hoechst Ag Phosphonoessigsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
FR2812546B1 (fr) * 2000-08-01 2008-11-21 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
TWI283577B (en) 1999-10-11 2007-07-11 Sod Conseils Rech Applic Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof
FR2799461B1 (fr) * 1999-10-11 2002-01-04 Sod Conseils Rech Applic Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments
WO2002094798A1 (fr) * 2001-05-23 2002-11-28 Nippon Soda Co.,Ltd. Preparation de composes thiazole
JPWO2006016399A1 (ja) * 2004-08-10 2008-05-01 株式会社静岡カフェイン工業所 ヒドロキサム酸誘導体及びそれを有効成分とする医薬
EP1939181A1 (en) 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
CN114516824A (zh) * 2022-03-18 2022-05-20 广州佳途科技股份有限公司 一种硫代酰胺羧酸酯及其合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (fi) * 1965-10-07
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds
US4535165A (en) * 1981-11-23 1985-08-13 Riker Laboratories, Inc. Substituted diazoles and thiazoles
JPS62132871A (ja) * 1985-12-03 1987-06-16 Yamanouchi Pharmaceut Co Ltd 新規チアゾ−ル誘導体
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative

Also Published As

Publication number Publication date
FI906141A (fi) 1991-06-16
JPH0517459A (ja) 1993-01-26
NO905411L (no) 1991-06-17
AU630261B2 (en) 1992-10-22
EP0432740A2 (de) 1991-06-19
ATE119527T1 (de) 1995-03-15
PT96181A (pt) 1991-09-30
IL96659A0 (en) 1991-09-16
AU6802490A (en) 1991-06-20
DE3941438A1 (de) 1991-06-20
IE904515A1 (en) 1991-06-19
NZ236453A (en) 1992-07-28
CA2032282A1 (en) 1991-06-16
EP0432740A3 (en) 1992-01-02
HUT58306A (en) 1992-02-28
RU2021264C1 (ru) 1994-10-15
RU2017739C1 (ru) 1994-08-15
EP0432740B1 (de) 1995-03-08
US5137897A (en) 1992-08-11
KR910011813A (ko) 1991-08-07
FI906141A0 (fi) 1990-12-13
HU209584B (en) 1994-08-29
HU908258D0 (en) 1991-06-28
NO905411D0 (no) 1990-12-14

Similar Documents

Publication Publication Date Title
ZA9010067B (en) Novel 2-substituted 4-(3-alkyl-5-tert-butyl-4-hydroxyphenyl)thiazoles,processes for their preparation,pharmaceuticals containing them and their use
ATE76066T1 (de) 1,2,5,6-tetrahydropyridin-3carboxaldehydoximderivate, verfahren zur herstellung, sie enthaltende zusammensetzungen und deren anwendung als heilmittel.
PT74356B (en) Process for the preparation of 2-penem
OA07257A (fr) Acides (oxo-4-4h-(1)-benzopyran-8-yl) alcanoïque, sels et dérivés, préparation et médicaments les contenant.
DK8881A (da) Ikke-ioniske 5-c-substituerede 2,4,6-trijodisophthalsyrederivater
SE8107292L (sv) 5,5'-azobis-salicylsyra samt farmakologiskt acceptabla salter derav
DE59208383D1 (de) Neue 17beta-substituierte Aza-androstan-Derivate
DK0573318T3 (da) 4-phenylcarbamoyl-3-isoxazolcarboxylsyreforbindelser, fremgangsmåde til deres fremstilling, farmaceutiske præparater med in
ES8303279A1 (es) "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos".
PT76196A (fr) Procede de preparation de derives d'imidazolidine et de compositions pharmaceutiques les contenant
DE3261515D1 (en) Benzopyranyl ethers, process for their preparation and medicine containing those compounds and intermediates
MX9205365A (es) Imidazolilmetil-piridinas y composicion farmaceutica que las contiene.
PT75533A (fr) Procede de preparation de derives de phenoxy-3 propanol-2 et de compositions pharmaceutiques les contenant
SE8205868L (sv) Vissa 4-fenyl-4-oxo-2-butensyraderivat till anvendning som lekemedel och kompositioner innehallande dem
ES466168A1 (es) Procedimiento para la preparacion de nuevos derivados de cromonas dotados de actividad medicamentosa
DK0419610T3 (da) Leukotrien-B4-derivater og fremgangsmåde til fremstilling deraf
DE68917907D1 (de) Tuftsin-Analoge und Impfstoffe, die diese Analoge als Adjuvantien enthalten.
DE3365954D1 (en) The use of alpha, alpha-dialkyl adamanthylethylamines to treat measles
ES8702420A1 (es) Procedimiento para la obtencion de compuestos de aminoal- quilpenem
ATE6063T1 (de) Cycloalkano-thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE3882956T2 (de) Gegen die zerebrale Insuffizienz wirksame Verbindungen.
SE8306884D0 (sv) Akrylsyraderivat innehallande en syrehaltig heterocykel till anvendning som lekemedel, nya industriprodukter och framstellningsforfarande
ATE150311T1 (de) Verwendung von isokarbacyclinen zur vorbeugung oder behandlung von organkrankheiten
NO167382C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer.
ES478502A1 (es) Un procedimiento para la preparacion de nuevas n-(piridotie-nopirazol)amidas